Steroid 5 alpha-reductase 2 deficiency

Carregando...
Imagem de Miniatura
Citações na Scopus
72
Tipo de produção
article
Data de publicação
2016
Título da Revista
ISSN da Revista
Título do Volume
Editora
PERGAMON-ELSEVIER SCIENCE LTD
Citação
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, v.163, p.206-211, 2016
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Dihydrotestosterone is a potent androgen metabolite formed from testosterone by action of 5 alpha-reductase isoenzymes. Mutations in the type 2 isoenzyme cause a disorder of 46,XY sex development, termed 5a-reductase type 2 deficiency and that was described forty years ago. Many mutations in the encoding gene have been reported in different ethnic groups. In affected 46,XY individuals, female external genitalia are common, but Mullerian ducts regress, and the internal urogenital tract is male. Most affected males are raised as females, but virilization occurs at puberty, and male social sex develops thereafter with high frequency. Fertility can be achieved in some affected males with assisted reproduction techniques, and adults with male social sex report a more satisfactory sex life and quality of life as compared to affected individuals with female social sex.
Palavras-chave
Disorders of sexual differentiation (DSD), Ambiguous genitalia, Gender identity/behavior, Androgen action, Dihydrotestosterone
Referências
  1. Achermann JC, 2015, NAT REV ENDOCRINOL, V11, P478, DOI 10.1038/nrendo.2015.69
  2. Amaral RC, 2015, CLIN ENDOCRINOL, V82, P159, DOI 10.1111/cen.12561
  3. ANDERSSON S, 1991, NATURE, V354, P159, DOI 10.1038/354159a0
  4. Bahceci M, 2005, UROLOGY, V66, P407, DOI 10.1016/j.urology.2005.02.021
  5. BOUDON C, 1995, CLIN ENDOCRINOL, V43, P183, DOI 10.1111/j.1365-2265.1995.tb01913.x
  6. BRUCHOVSKY N, 1968, J BIOL CHEM, V243, P5953
  7. BRUCHOVSKY N, 1968, J BIOL CHEM, V243, P2012
  8. Cai LQ, 1996, J CLIN ENDOCR METAB, V81, P1730, DOI 10.1210/jc.81.5.1730
  9. Can S, 1998, J CLIN ENDOCR METAB, V83, P560, DOI 10.1210/jc.83.2.560
  10. Canto P, 1997, CLIN ENDOCRINOL, V46, P155, DOI 10.1046/j.1365-2265.1997.800904.x
  11. Chan AOK, 2013, CLIN CHEM, V59, P798, DOI 10.1373/clinchem.2012.196501
  12. Chavez B, 2000, J CLIN ENDOCR METAB, V85, P3147, DOI 10.1210/jc.85.9.3147
  13. Cohen-Kettenis PT, 2005, ARCH SEX BEHAV, V34, P399, DOI 10.1007/s10508-005-4339-4
  14. Costa EMF, 2012, SEMIN REPROD MED, V30, P427, DOI 10.1055/s-0032-1324727
  15. Costa EMF, 1997, FERTIL STERIL, V67, P229
  16. Erdeve SS, 2010, EUR J PEDIATR, V169, P991, DOI 10.1007/s00431-010-1163-1
  17. Ferraz LFC, 1999, AM J MED GENET, V87, P221, DOI 10.1002/(SICI)1096-8628(19991126)87:3<221::AID-AJMG5>3.0.CO;2-#
  18. Frade Costa E M, 2001, Rev Hosp Clin Fac Med Sao Paulo, V56, P139
  19. FREDERIKSEN DW, 1971, J BIOL CHEM, V246, P2584
  20. Gad YZ, 1997, J INHERIT METAB DIS, V20, P95, DOI 10.1023/A:1005326027087
  21. Griffin J., 2000, METABOLIC MOL BASES
  22. Guercio Gabriela, 2014, Endocr Dev, V27, P87, DOI 10.1159/000363633
  23. Hackel C, 2005, J MOL MED-JMM, V83, P569, DOI 10.1007/s00109-005-0651-7
  24. Hochberg Z, 1996, J CLIN ENDOCR METAB, V81, P2821, DOI 10.1210/jc.81.8.2821
  25. IMPERATO.J, 1974, SCIENCE, V186, P1213, DOI 10.1126/science.186.4170.1213
  26. Imperato-McGinley J, 1997, Curr Ther Endocrinol Metab, V6, P384
  27. IMPERATOMCGINLEY J, 1991, CLIN ENDOCRINOL, V34, P293, DOI 10.1111/j.1365-2265.1991.tb03769.x
  28. Kang HJ, 2011, FERTIL STERIL, V95, DOI 10.1016/j.fertnstert.2011.01.121
  29. KATZ MD, 1995, J CLIN ENDOCR METAB, V80, P3160, DOI 10.1210/jc.80.11.3160
  30. Katz MD, 1997, NEW ENGL J MED, V336, P994, DOI 10.1056/NEJM199704033361404
  31. MacLaughlin DT, 2004, NEW ENGL J MED, V350, P367, DOI 10.1056/NEJMra022784
  32. Maimoun L, 2011, J CLIN ENDOCR METAB, V96, P296, DOI 10.1210/jc.2010-1024
  33. Marzuki NS, 2010, J PEDIATR ENDOCR MET, V23, P1329, DOI 10.1515/jpem.2010.207
  34. Matsubara K, 2010, FERTIL STERIL, V94, DOI 10.1016/j.fertnstert.2010.04.013
  35. Mazen I, 2003, J PEDIATR ENDOCR MET, V16, P219
  36. MENDONCA B B, 1987, Revista do Hospital das Clinicas da Faculdade de Medicina da Universidade de Sao Paulo, V42, P66
  37. Mendonca B.B., 2013, ENDOTEXT
  38. Mendonca BB, 1996, MEDICINE, V75, P64, DOI 10.1097/00005792-199603000-00003
  39. Mendonca BB, 2014, CURR OPIN ENDOCRINOL, V21, P511, DOI 10.1097/MED.0000000000000115
  40. Mendonca BB, 2009, CLIN ENDOCRINOL, V70, P173, DOI [10.1111/j.1365-2265.2008.03392.x, 10.1111/j.1365-2265.2008.03492.x]
  41. MILEWICH L, 1995, J CLIN ENDOCR METAB, V80, P3136, DOI 10.1210/jc.80.11.3136
  42. NG WK, 1990, ARCH DIS CHILD, V65, P1166
  43. Nie M, 2011, MOL HUM REPROD, V17, P57, DOI 10.1093/molehr/gaq072
  44. NOWAKOWSKI H, 1961, RECENT PROG HORM RES, V17, P53
  45. Ocal G, 2002, J PEDIATR ENDOCR MET, V15, P411
  46. OKON E, 1980, ARCH PATHOL LAB MED, V104, P363
  47. Sircili MHP, 2010, J UROLOGY, V184, P1122, DOI 10.1016/j.juro.2010.05.022
  48. PRICE P, 1984, J CLIN INVEST, V74, P1496, DOI 10.1172/JCI111563
  49. Russell DW, 2014, GENETIC STEROID DISORDERS, P199, DOI 10.1016/B978-0-12-416006-4.00014-4
  50. RUSSELL DW, 1994, ANNU REV BIOCHEM, V63, P25, DOI 10.1146/annurev.biochem.63.1.25
  51. Sahakitrungruang T., 2015, FERTIL STERIL, V90
  52. Sahu R, 2009, J PEDIATR ENDOCR MET, V22, P247
  53. Silver RI, 1999, J UROLOGY, V162, P1142, DOI 10.1016/S0022-5347(01)68102-3
  54. Sircili Maria Helena Palma, 2006, Clinics, V61, P209, DOI 10.1590/S1807-59322006000300005
  55. Sobel V, 2006, J CLIN ENDOCR METAB, V91, P3017, DOI 10.1210/jc.2005-2809
  56. THIGPEN AE, 1992, J CLIN INVEST, V90, P799, DOI 10.1172/JCI115954
  57. Veiga-Junior N.N., 2012, INT J ENDOCRINOL, V2012
  58. WALSH PC, 1974, NEW ENGL J MED, V291, P944, DOI 10.1056/NEJM197410312911806
  59. Walter KN, 2010, HORM RES PAEDIAT, V74, P67, DOI 10.1159/000313372
  60. WIGLEY WC, 1994, BIOCHEMISTRY-US, V33, P1265, DOI 10.1021/bi00171a029
  61. WILSON JD, 1993, ENDOCR REV, V14, P577, DOI 10.1210/er.14.5.577
  62. WILSON JD, 1972, NEW ENGL J MED, V287, P1284